| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 06/27/2000 | CA2076744C Viral agent associated with mystery swine disease |
| 06/22/2000 | WO2000036415A1 Method and device for the cell-track-based examination and cultivation of cells |
| 06/22/2000 | WO2000036143A2 Selecting animals for parentally imprinted traits |
| 06/22/2000 | WO2000036138A1 Screening for inhibitors of terpenoids biosynthesis |
| 06/22/2000 | WO2000036135A2 Screening methods based on the use of protein kinases |
| 06/22/2000 | WO2000036129A1 Enhanced protein production in higher plants by n-terminal fusion of a ubiquitin or a cucumber mosaic virus coat protein peptide |
| 06/22/2000 | WO2000036126A1 Thioredoxin and grain processing |
| 06/22/2000 | WO2000036118A2 HUMAN CYCLIN-DEPENDENT KINASE (hPNQALRE) |
| 06/22/2000 | WO2000036113A2 Extending graft survival by heme oxygenase-i expression induced immunomodulation |
| 06/22/2000 | WO2000036112A1 Mutants of rna polymerases with increased stability |
| 06/22/2000 | WO2000036111A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp |
| 06/22/2000 | WO2000036110A2 Plant disease resistance genes |
| 06/22/2000 | WO2000036108A2 Il-1 zeta, il-1 zeta splice variants and xrec2 dnas and polypeptides |
| 06/22/2000 | WO2000036107A2 Compositions and methods for therapy and diagnosis of ovarian cancer |
| 06/22/2000 | WO2000036105A1 Prostacyclin-stimulating factor-2 |
| 06/22/2000 | WO2000036104A1 Pancreatic polypeptide zsig66 |
| 06/22/2000 | WO2000036103A1 Cytokine receptor chain |
| 06/22/2000 | WO2000036102A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 06/22/2000 | WO2000036095A2 FATTY ACYL-CoA: FATTY ALCOHOL ACYLTRANSFERASES |
| 06/22/2000 | WO2000036093A2 Intein-mediated cyclization of peptides |
| 06/22/2000 | WO2000036092A2 METHOD FOR THE HIGH LEVEL EXPRESSION OF ACTIVE LYMPHOTOXIN-β RECEPTOR IMMUNOGLOBULIN CHIMERIC PROTEINS AND THEIR PURIFICATION |
| 06/22/2000 | WO2000036091A2 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells |
| 06/22/2000 | WO2000036090A2 Human brain endothelial cells and growth medium and method for expansion of primitive cd34+cd38- bone marrow stem cells |
| 06/22/2000 | WO2000036089A2 Methods of immunosuppression |
| 06/22/2000 | WO2000036088A1 Improved methods for insertion of nucleic acids into circular vectors |
| 06/22/2000 | WO2000036081A2 Materials and methods for the modification of isoprenoid content, composition and metabolism |
| 06/22/2000 | WO2000035956A1 Antihuman vegf monoclonal antibody |
| 06/22/2000 | WO2000035950A2 Reagents and methods useful for detecting diseases of the breast |
| 06/22/2000 | WO2000035949A1 Compositions and methods for enhancement of major histocompatibility complex class i restricted antigen presentation |
| 06/22/2000 | WO2000035948A1 Methods and compositions for treating disorders involving excitotoxicity |
| 06/22/2000 | WO2000035946A1 Methods |
| 06/22/2000 | WO2000035937A1 47 human secreted proteins |
| 06/22/2000 | WO2000035483A1 Methods and products for regulating lectin complement pathway associated complement activation |
| 06/22/2000 | WO2000035471A1 Soluble haemopoietin receptor nr6 (clf-1) and uses thereof |
| 06/22/2000 | WO2000012709A3 Phelix: a testis-specific protein expressed in cancer |
| 06/22/2000 | WO2000012703A3 Protein transport-associated molecules |
| 06/22/2000 | WO2000012544A3 Novel irap-bp polypeptide and nucleic acid molecules and uses therefor |
| 06/22/2000 | WO2000012122A3 Low-molecular fragments of hyaluronic acid for the preparation of vaccines |
| 06/22/2000 | WO2000011033A3 Expression and export of angiostatin and endostatin as immunofusins |
| 06/22/2000 | WO2000009667A9 Calcineurin-dependent control of skeletal muscle fiber type |
| 06/22/2000 | WO2000009538A3 Canine growth hormone secretagogue receptor |
| 06/22/2000 | WO2000007430A3 Plant fatty acid desaturase promoters |
| 06/22/2000 | WO2000006759A3 Anti-angiogenesis plasmids and delivery systems, and methods of making and using the same |
| 06/22/2000 | WO2000006736A3 Nucleic acids and proteins from group b streptococcus |
| 06/22/2000 | WO2000001231A3 Improved methods for storing neural cells |
| 06/22/2000 | WO2000001221A3 Methods for interspecific hybridization |
| 06/22/2000 | WO2000000158A9 Alkylamines and their precursors as specific modulators of human gamma-delta t cell function |
| 06/22/2000 | WO1999065937A3 Truncated apaf-1 and methods of use thereof |
| 06/22/2000 | WO1999057282A3 Pesticidal toxins and nucleotide sequences which encode these toxins |
| 06/22/2000 | CA2440933A1 An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof |
| 06/22/2000 | CA2362423A1 47 human secreted proteins |
| 06/22/2000 | CA2355971A1 An animal model for identifying a common stem/progenitor to liver cells and pancreatic cells |
| 06/22/2000 | CA2355934A1 Intein mediated cyclization of peptides |
| 06/22/2000 | CA2355870A1 Reagents and methods useful for detecting diseases of the breast |
| 06/22/2000 | CA2355363A1 Prostacyclin-stimulating factor-2 |
| 06/22/2000 | CA2355362A1 Screening methods based on the use of protein kinases |
| 06/22/2000 | CA2355349A1 Improved methods for insertion of nucleic acids into circular vectors |
| 06/22/2000 | CA2355066A1 Extending graft survival by heme oxygenase-i expression induced immunomodulation |
| 06/22/2000 | CA2355039A1 Pancreatic polypeptide zsig66 |
| 06/22/2000 | CA2354539A1 A method for the high level expression of active lymphotoxin-.beta. receptor immunoglobulin chimeric proteins and their purification |
| 06/22/2000 | CA2354156A1 Compositions and methods for therapy and diagnosis of ovarian cancer |
| 06/22/2000 | CA2354147A1 Methods of immunosuppression |
| 06/22/2000 | CA2353997A1 Therapeutic and diagnostic uses of protein tyrosine phosphatase tc-ptp |
| 06/22/2000 | CA2353910A1 Materials and methods for the modification of isoprenoid content, composition and metabolism |
| 06/22/2000 | CA2353794A1 Thioredoxin and grain processing |
| 06/22/2000 | CA2353561A1 Human brain endothelial cells and growth medium and method for expansion of primitive cd34+cd38- bone marrow stem cells |
| 06/22/2000 | CA2352570A1 Methods and compositions for treating disorders involving excitotoxicity |
| 06/22/2000 | CA2352473A1 Fatty acyl-coa: fatty alcohol acyltransferases |
| 06/22/2000 | CA2290220A1 An infectious cdna clone of north american porcine reproductive and respiratory syndrome (prrs) virus and uses thereof |
| 06/21/2000 | EP1010760A1 Lumazine synthase and riboflavin synthase |
| 06/21/2000 | EP1010756A1 Mesothelial cells from the visceral pleura |
| 06/21/2000 | EP1010007A1 Collagen-peptide assay method |
| 06/21/2000 | EP1009855A1 Method for separating cells |
| 06/21/2000 | EP1009847A1 Conjugates that contain the homeodomain of antennapedia |
| 06/21/2000 | EP1009846A1 Alphavirus-derived vectors useful as vaccines providing protection against paramyxovirus infection |
| 06/21/2000 | EP1009844A1 IMPROVED $i(AGROBACTERIUM)-MEDIATED TRANSFORMATION OF PLANTS |
| 06/21/2000 | EP1009843A1 Selective expression of genes in plants |
| 06/21/2000 | EP1009842A1 Plasmids for plant transformation and method for using the same |
| 06/21/2000 | EP1009840A1 Protein complementation in transgenic plants |
| 06/21/2000 | EP1009838A2 Method for protecting plants |
| 06/21/2000 | EP1009834A1 Regulation of protein secretion |
| 06/21/2000 | EP1009833A1 Prenylcysteine carboxyl methyl-transferase, dna enconding same, and a method of screening for inhibitors thereof |
| 06/21/2000 | EP1009832A1 Cytokine designated lerk-6 |
| 06/21/2000 | EP1009831A2 Agonist antibodies to the thrombopoietin receptor, and their therapeutic uses |
| 06/21/2000 | EP1009826A1 Erbb4 receptor-specific neuregulin, related ligands and uses thereof |
| 06/21/2000 | EP1009824A1 COMPOSITIONS AND METHODS FOR MODULATING CELLULAR NF-kappaB ACTIVATION |
| 06/21/2000 | EP1009817A1 Rtd receptor |
| 06/21/2000 | EP1009814A1 Human receptor tyrosine kinase, kdr |
| 06/21/2000 | EP1009812A1 Transgenic plants with tocopherol methyltransferase |
| 06/21/2000 | EP1009808A2 Methods for generating high titer helper-free preparations of recombinant aav vectors |
| 06/21/2000 | EP1009807A1 DIFFERENTIAL LIGAND ACTIVATION OF ESTROGEN RECEPTORS ER$g(a) AND ER$g(b) AT AP1 SITES |
| 06/21/2000 | EP1009806A2 Method for the treatment or diagnosis of human pathologies with disseminated or difficult to access cells or tissues |
| 06/21/2000 | EP1009805A1 TRANSGENIC PLANTS OF ALTERED MORPHOLOGY AND THE ISOLATED $i(ARABIDOPSIS THALIANA) ENDO-1,4-$g(b)-GLUCANASE GENE, PROMOTER AND PROTEIN |
| 06/21/2000 | EP1009804A1 Nucleic acid sequences encoding capsaicin receptor and capsaicin receptor-related polypeptides and uses thereof |
| 06/21/2000 | EP1009772A1 Monoclonal antibodies that bind testosterone |
| 06/21/2000 | EP1009768A1 Persephin and related growth factors |
| 06/21/2000 | EP1009767A1 HUMAN DEFENSIN DEF-X, GENE AND DNAc, COMPOSITION CONTAINING SAME AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 06/21/2000 | EP1009765A1 EPO PRIMARY RESPONSE GENE, EPRG3Spt |
| 06/21/2000 | EP1009764A1 VACCINE COMPOSITIONS COMPRISING THE $i(HELICOBACTER PYLORI) FlgE POLYPEPTIDE |
| 06/21/2000 | EP1009762A2 Lipocalin homologs |